Evaluation of PIK3CA mutation as a predictor of benefit from NSAID therapy in colorectal cancer
暂无分享,去创建一个
D. Kerr | O. Sieber | I. Tomlinson | E. Domingo | B. Davidson | D. Church | R. Midgley | R. Ramamoorthy
暂无分享,去创建一个
D. Kerr | O. Sieber | I. Tomlinson | E. Domingo | B. Davidson | D. Church | R. Midgley | R. Ramamoorthy